Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Comparison of Two-treadmill Test Protocols to Evaluate Endurance in People With Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT01111032
Recruitment Status : Completed
First Posted : April 27, 2010
Last Update Posted : October 1, 2013
Sponsor:
Collaborator:
McMaster University
Information provided by (Responsible Party):
Oren Cheifetz, McMaster University

Tracking Information
First Submitted Date April 26, 2010
First Posted Date April 27, 2010
Last Update Posted Date October 1, 2013
Study Start Date May 2011
Actual Primary Completion Date October 2011   (Final data collection date for primary outcome measure)
Current Primary Outcome Measures
 (submitted: September 29, 2013)
STEEP treadmill test [ Time Frame: 1 hour ]
Treadmill test for endurance. Lasts approx 15 min with 45 min recovery
Original Primary Outcome Measures Not Provided
Change History Complete list of historical versions of study NCT01111032 on ClinicalTrials.gov Archive Site
Current Secondary Outcome Measures Not Provided
Original Secondary Outcome Measures Not Provided
Current Other Pre-specified Outcome Measures Not Provided
Original Other Pre-specified Outcome Measures Not Provided
 
Descriptive Information
Brief Title Comparison of Two-treadmill Test Protocols to Evaluate Endurance in People With Cancer
Official Title Comparison of Two-treadmill Test Protocols to Evaluate Endurance in People With Cancer.
Brief Summary During this study the investigators will compare the use of two treadmill tests in people diagnosed with cancer. The STEEP treadmill protocol is often used to evaluate the endurance of people diagnosed with cancer, however, since it is based on step increases in speed or ramp, it may not related to normal function. The new test, which is based on the body response to increased activity has not been used with people with cancer but may provide a better approximation of endurance demands during daily function. Our question is whether the new treadmill test can be used to evaluate aerobic function with people with cancer better than the STEEP treadmill test.
Detailed Description Not Provided
Study Type Observational
Study Design Observational Model: Cohort
Time Perspective: Prospective
Target Follow-Up Duration Not Provided
Biospecimen Not Provided
Sampling Method Non-Probability Sample
Study Population Adult well cancer survivors
Condition Cancer
Intervention Not Provided
Study Groups/Cohorts Treadmill test
Publications * Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruitment Information
Recruitment Status Completed
Actual Enrollment
 (submitted: September 29, 2013)
12
Original Estimated Enrollment
 (submitted: April 26, 2010)
20
Actual Study Completion Date December 2011
Actual Primary Completion Date October 2011   (Final data collection date for primary outcome measure)
Eligibility Criteria

Inclusion Criteria:

  • Participants are required to be adults (age 16 or over),
  • Diagnosed with cancer, at any stage of treatment (during or after treatment),
  • Able to follow instructions in English, and provide informed consent.
  • Participants need to be considered "well" to participate. A "well participant" has been defined as a cancer survivor who is living at home, able to ambulate independently without a gait aid (single point cane is acceptable), has no acute medical conditions, and passes pre-exercise safety screening.

Exclusion Criteria:

  • Cancer survivors with metastatic disease.
  • Cancer survivors who are defined as unwell.
Sex/Gender
Sexes Eligible for Study: All
Ages 16 Years and older   (Child, Adult, Older Adult)
Accepts Healthy Volunteers No
Contacts Contact information is only displayed when the study is recruiting subjects
Listed Location Countries Canada
Removed Location Countries  
 
Administrative Information
NCT Number NCT01111032
Other Study ID Numbers Treadmill Comparison
Has Data Monitoring Committee No
U.S. FDA-regulated Product Not Provided
IPD Sharing Statement Not Provided
Responsible Party Oren Cheifetz, McMaster University
Study Sponsor Hamilton Health Sciences Corporation
Collaborators McMaster University
Investigators
Principal Investigator: Oren Cheifetz, M.Sc. PT Hamilton Health Sciences Corporation
PRS Account McMaster University
Verification Date September 2013